Location: Home
  • search
  • go
  • WiCON News
    Pharma China adds another distinguished industry leader to its advisory board 10/27/2008
    Pharma China is honored to announce the addition of another distinguished pharma industry leader, Stanley Lau, to our advisory board.

    Stanley Lau is a seasoned senior executive in the healthcare field for the last twenty five years. He began his career in retail pharmacy and worked as a pharmacy manager in London. He joined Pfizer in 1981 in sales operation and subsequently in marketing position in Hong Kong. Stanley joined Merck Sharp & Dohme in 1987 to become regional sales director responsible for its sales function in Asia region. He was then transferred to the headquarters in New Jersey supporting Latin American and Middle Eastern regions. In 1991 he was appointed as the first general manager of MSD Taiwan, changing the operation from a distributor model to a full subsidiary operation. In 1994, Stanley became general manager of Schering Plough China and set up its first JV in this promising market. He went back to run Asia region as general manager of Searle / Pharmacia from 1999 to 2002. In the last six years he worked at Baxter as general manager of Baxter China and most recently as strategic advisor to the President of Baxter Asia Pacific region.

    Stanley has a BPharm from London University and attended management studies at Columbia University, New York.

    Pharma China's Advisory Board is consisted of 11 distinguished senior pharmaceutical executives with a wealth of expertise in the Chinese pharmaceutical and healthcare sector. They are:

    Dr Rob Bryant - Principal, Brychem Business Consulting
    Peter Chua President, Association of Hong Kong Healthcare Professionals; Member, the Pharmacy & Poisons Board of the Hong Kong Government; President, Huatai Pharmaceutical Ltd., Hong Kong; Director, Beijing United Pharmaceutical Ltd.; Justice of Peace (HK); and former President, Hong Kong Pharmaceutical Society.

    Dr Ming Pang – Independent consultant, board member of a number of pharma ventures in China and Hong Kong, and former Chairman/CEO, Baker Norton Asia.

    Stanley Lau – Strategic Advisor to the President of Baxter Asia Pacific; former GM - Baxter China; former GM - Schering Plough China; former GM Asia – Searle/Pharmacia; and former GM, MSD Taiwan

    Robert Pollard – Director, Synovate Healthcare China

    Dr. Xiaomei Li Reckford, Vice President, China Development, Quintiles Transnational Corporation; Former CEO, Quintiles Greater China
    Dr. Jiaxiang Shen - Senior Fellow, Chinese Academy of Engineering; Honorary Chairman, the Pharmacy College of Tianjin University; and advisor to many Chinese government agencies; and former Deputy Chief Engineer, State Pharmaceutical Administration of China; and former President, National Institutes for Pharmaceutical R&D

    Peter Scheuer – Head of Legal Affairs, Bayer Healthcare China; and former Executive Director, R&D-based Pharmaceutical Association in China (RDPAC)

    Dr. Dong XieChairman and CEO, Frontier Biotechnology Ltd.

    Cheryl Q. XuAdvisor on China, Pharmaceutical Research and Manufacturers of America (PhRMA) and President, Aquila Health Consulting

    Dr. Weiping YangChairman and CEO, Fresenius Kabi China; and Director, RDPAC
  • Site map | Contact Us | Links
  • © Wicon International Group Support by: www.heightow.com